Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

BIAL Announces Oral Presentation at GBA1 Meeting 2025

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BIAL-SA-GBA1-Meeting

More Like This

PR Newswire associated0

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT

Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

PR Newswire associated0

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

Long-term treatment data for lecanemab to be presented at AAIC 2024

BenevolentAI Announces Positive Topline Safety and Pharmacokinetic Data from the Phase Ia Clinical Study of BEN-8744 in Healthy Volunteers

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us